VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model
- PMID: 15164063
- DOI: 10.1038/nature02544
VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model
Abstract
Amyotrophic lateral sclerosis (ALS) causes adult-onset, progressive motor neuron degeneration in the brain and spinal cord, resulting in paralysis and death three to five years after onset in most patients. ALS is still incurable, in part because its complex aetiology remains insufficiently understood. Recent reports have indicated that reduced levels of vascular endothelial growth factor (VEGF), which is essential in angiogenesis and has also been implicated in neuroprotection, predispose mice and humans to ALS. However, the therapeutic potential of VEGF for the treatment of ALS has not previously been assessed. Here we report that a single injection of a VEGF-expressing lentiviral vector into various muscles delayed onset and slowed progression of ALS in mice engineered to overexpress the gene coding for the mutated G93A form of the superoxide dismutase-1 (SOD1(G93A)) (refs 7-10), even when treatment was only initiated at the onset of paralysis. VEGF treatment increased the life expectancy of ALS mice by 30 per cent without causing toxic side effects, thereby achieving one of the most effective therapies reported in the field so far.
Similar articles
-
Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.J Neurosci. 2002 Aug 15;22(16):6920-8. doi: 10.1523/JNEUROSCI.22-16-06920.2002. J Neurosci. 2002. PMID: 12177190 Free PMC article.
-
Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.Neurobiol Dis. 2000 Dec;7(6 Pt B):623-43. doi: 10.1006/nbdi.2000.0299. Neurobiol Dis. 2000. PMID: 11114261
-
In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.Exp Neurol. 2006 Oct;201(2):293-300. doi: 10.1016/j.expneurol.2006.04.007. Epub 2006 Jun 5. Exp Neurol. 2006. PMID: 16740261
-
VEGF at the neurovascular interface: therapeutic implications for motor neuron disease.Biochim Biophys Acta. 2006 Nov-Dec;1762(11-12):1109-21. doi: 10.1016/j.bbadis.2006.04.005. Epub 2006 May 9. Biochim Biophys Acta. 2006. PMID: 16784838 Review.
-
Amyotrophic lateral sclerosis models and human neuropathology: similarities and differences.Acta Neuropathol. 2008 Jan;115(1):97-114. doi: 10.1007/s00401-007-0308-4. Epub 2007 Nov 17. Acta Neuropathol. 2008. PMID: 18026741 Review.
Cited by
-
The advancement of siRNA-based nanomedicine for tumor therapy.Nanomedicine (Lond). 2024;19(21-22):1841-1862. doi: 10.1080/17435889.2024.2377062. Epub 2024 Aug 15. Nanomedicine (Lond). 2024. PMID: 39145477 Review.
-
Therapeutics Targeting Skeletal Muscle in Amyotrophic Lateral Sclerosis.Biomolecules. 2024 Jul 22;14(7):878. doi: 10.3390/biom14070878. Biomolecules. 2024. PMID: 39062592 Free PMC article. Review.
-
2(3H)-Dihydrofranolactone metabolites from Pleosporales sp. NUH322 as anti-amyotrophic lateral sclerosis drugs.J Nat Med. 2024 Jan;78(1):146-159. doi: 10.1007/s11418-023-01751-5. Epub 2023 Oct 7. J Nat Med. 2024. PMID: 37804412
-
Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders.Pharmaceuticals (Basel). 2023 Aug 11;16(8):1140. doi: 10.3390/ph16081140. Pharmaceuticals (Basel). 2023. PMID: 37631054 Free PMC article. Review.
-
Preservation of KCC2 expression in axotomized abducens motoneurons and its enhancement by VEGF.Brain Struct Funct. 2023 May;228(3-4):967-984. doi: 10.1007/s00429-023-02635-w. Epub 2023 Apr 1. Brain Struct Funct. 2023. PMID: 37005931 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous